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The  activity  of  specific  anti-venom  can  be  demonstrated  using  protection  test  in 
laboratory  mice.  Our  study  aimed  to  emphasize  the  possibility  of  viper  venom 
inactivation by the antibodies produced and isolated from duck eggs and also to the 
activation concentration of these antibodies. The venom used for inoculation was 
harvested  from  two  viper  species  (Vipera  ammodytes  and  Vipera  berus).  The 
immunoglobulin  extract  had  a  better  activity  on  the  venom  from  Vipera  berus 
compared to the venom from Vipera ammodytes. This could be the result of a better 
immunological  response,  as  consequence  of  the  immunization  with  this  type  of 
venom, compared to the response recorded when the Vipera ammodytes venom was 
used.   Besides the advantages of low cost, high productivity and reduced risk of 
anaphylactic shock, the duck eggs also have high activity up to dilutions of 1/16, 
1/32,  respectively,  with  specific  activity  and  100  surviving  in  individuals  which 
received 3 x DL50. 
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Introduction 
 
Since 1894 the anti-venom serums were produced. The French pathologist, 
Dr.  Albert  Calmette  was  the  first  who  demonstrated  the  venom  protection  in 
animals  when  immunization  was  performed  with  low  venom  doses  were  used. 
Calmette produced the first Naja kaouthia antiserum against venom in mule. In 
1895 the first antiserum produced in equine saved several individuals with severe 
bites.  50 
 
The activity of specific anti-venom can be demonstrated using protection test in 
laboratory  mice.  Our  study  aimed  to  emphasize  the  possibility  of  viper  venom 
inactivation by the antibodies produced and isolated from duck eggs and also to the 
activation concentration of these antibodies. 
 
Material and Methods 
 
Producing  of  the  anti-venom  antibodies.  Two  Pekin  ducks  were 
immunized  with  viper  venom  for  producing  antibodies.  The  venom  used  for 
inoculation was delivered from the bio base of the Department of Ecology from the 
University of agricultural Sciences and Veterinary Medicine Cluj – Napoca, and 
was harvested from two viper species (Vipera ammodytes and Vipera berus). Stock 
solutions 1 mg/mL in saline solution were prepared from venom. 500  L from each 
viper specie mixed with aluminum hydroxide as adjuvant, for amplification of the 
immune  response,  were  used  for  inoculation.  4  rappel  immunizations  were 
performed at 2 weeks interval. In the end of the immunization period, the eggs 
from the immunized ducks were harvested, and antibodies were isolated using the 
previously described method of dilution with distilled water and precipitation with 
ammonia sulfate. The isolated antibodies were re-suspended in a minimum volume 
of saline solution and photometrically quantified. The obtained mixture had 24.55 
mg IgY /mL content. 
 
The protection test 
Laboratory mice, 20 g weight each were used for the protection test. They were 
subcutaneous injected with venom – anti-venom mixture. 
Serial dilutions, in micro-method, within the interval 1:2, 1:4, 1:8, 1:16 etc., were 
obtained  from  the  immunoglobulin  extract  obtained  from  the  duck  eggs.  The 
dilutions were performed with saline solution for realizing the antigen – antibody 
complexes.  
After  dilution,  an  equal  venom  quantity  was  added  within  two  experimental 
variants: 
I
st Variant: 5 x DL 50 
II
nd Variant: 3 x DL 50 
The mixture was incubated for 60 minutes at 37
0C, and then inoculated in mouse. 
Two  mice,  individually  marked,  were  inoculated  with  each  dilution.  Control 
inoculations were also performed, 2 positive control mice inoculated only with 
venom and 2 negative control mice inoculated only with immunoglobulin extract. 
The mice were monitored at 2 hours interval during first 12 experimental hours. 
After 24 hours from inoculation the monitoring started.      51 
 
Results and Discussions 
 
After mice inoculation with venom doses incubated with dilution obtained from 
immunoglobulin extract, they were monitored for 24 hours.    
When 5 x DL 50 venom dose was used, 100% mortality of the individuals from 
positive control and experimental groups was recorded. Only the individuals who 
received immunoglobulin extract, from negative control group, survived.   
When 3 x DL 50 dilutions were used, mortality was not recorded in all cases. The 
results are synthesized in the following table: 
 
Table 5.5 
The  mortality  recorded  in  mice  as  result  of  the  protection  test  performed  for 
emphasizing the activity of the immunoglobulin extract  
Venom 
3 x DL 50 
Positive 
control 
Negative 
control 
1:2  1:4  1:8  1:16  1:32  1:64  1:128  1:256  1:512 
Vipera 
berus 
2  -  -  -  -  -  -  1  2  2  2 
Vipera 
ammodytes 
2  -  -  -  -  1  2  2  2  2  2 
 
The  mixture  venom  and  immunoglobulin  extract  had  different  action 
function  of  the  venom  origin.    When  Vipera  berus  venom  was  used,  100% 
surviving was recorded in tested individuals up to the dilution of 1:32, while the 
use of the dilution of 1:64 had as result 50% surviving in tested individuals. Higher 
dilutions  of  the  immunoglobulin  extract  led  to  100%  mortality  in  treated 
individuals. 
The use of the Vipera ammodytes venom led to 100% surviving in tested 
individuals up to the dilution of de 1:16, while the use of the dilution of 1:32 had as 
result 50% surviving in tested individuals. Higher dilutions of the immunoglobulin 
extract led to 100% mortality in treated individuals. 
The  immunoglobulin  extract  had  a  better  activity  on  the  venom  from 
Vipera berus compared to the venom from Vipera ammodytes. This could be the 
result of a better immunological response, as consequence of the immunization 
with  this  type  of  venom,  compared  to  the  response  recorded  when  the  Vipera 
ammodytes venom was used.   
Besides the advantages of low cost, high productivity and reduced risk of 
anaphylactic shock, the duck eggs also have high activity up to dilutions of 1/16, 
1/32, respectively, with specific activity and 100 surviving in individuals which 
received 3 x DL50. 
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Conclusions 
 
Other advantages of the aviary antibodies resulted from the protection test 
performed in laboratory mice with the aim of emphasizing the activity of the ant-
venom  from  Vipera  ammodytes  and  Vipera  berus.  Besides  high  activity,  the 
obtained  antibodies  have  low  cost,  high  productivity  and  reduce  the  risk  of 
anaphylactic shock recorded when other anti-venom serums are used. 
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